We need to ask ourselves: What use is our scientific endeavor and innovation when they are inaccessible to the people who need them the most? It is only when the benefits of research reach the person on the lowest rung… — Kiran Mazumdar-Shaw Copy Share Image
In Vedic times, we had the great quest for the unknown. We did wonderful things; we celebrate our past vigyaan and our wonderful heritage… — Kiran Mazumdar-Shaw Copy Share Image
People believe that art and science are two distinct realms. It is far from the truth because, if you look at science from a… — Kiran Mazumdar-Shaw Copy Share Image
Unfortunately, our stock is somehow not well understood by the markets. The market compares us with generic companies. We need to look at Biocon… — Kiran Mazumdar-Shaw Copy Share Image
I want to make sure that our bio-similars capture a huge market share and help cancer patients around the world, which we are already… — Kiran Mazumdar-Shaw Copy Share Image
I have successfully challenged the Western world's existing model of pharmaceutical innovation, which leads to the creation of monopolistic markets for novel, life-saving drugs… — Kiran Mazumdar-Shaw Copy Share Image
I faced a number of challenges whilst I built Biocon. Initially, I had credibility challenges where I couldn't get banks to fund me; I… — Kiran Mazumdar-Shaw Copy Share Image
We need to ask ourselves: What use is our scientific endeavor and innovation when they are inaccessible to the people who need them the… — Kiran Mazumdar-Shaw Copy Share Image
As a traditionally risk-averse nation, India has rarely been at the forefront of innovation. Indian companies have mostly imitated others and became very good… — Kiran Mazumdar-Shaw Copy Share Image
Innovation and commerce are as powerful tools for creating social progress as they are for driving technological advancement. — Kiran Mazumdar-Shaw Copy Share Image
